Walleye Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
67,800
+67,700
+67,700% +$230K ﹤0.01% 3035
2026
Q1
$176 Sell
100
-56,500
-100% -$123K ﹤0.01% 4292
2025
Q4
$133K Buy
56,600
+43,500
+332% +$119K ﹤0.01% 3746
2025
Q3
$40.1K Buy
+13,100
New +$37.4K ﹤0.01% 4077
2025
Q1
Sell
-300
Closed -$945 4349
2024
Q4
$945 Buy
+300
New +$1.07K ﹤0.01% 4705

Other funds holding CLOV

Walleye Capital's CLOV Position: Q2 2026 in Review

Walleye Capital reduced its Clover Health Investments (CLOV) stake by 58% in Q2 2026, selling an estimated $48.3K and leaving 10,289 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Walleye Capital first reported a position in CLOV in Q2 2020 and has held it in 11 quarters since. The position peaked at $2.26M in Q2 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Walleye Capital held 10,289 shares of Clover Health Investments worth $53.9K as of Q2 2026.
  • Walleye Capital sold 14,223 Clover Health Investments shares in Q2 2026, an estimated $48.3K.
  • Clover Health Investments made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4159 holding.
  • Walleye Capital first reported a position in Clover Health Investments in Q2 2020 and has held it in 11 quarters since.
  • Walleye Capital's Clover Health Investments position peaked at $2.26M in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.